Controlled trials with four per cent cromolyn spray in seasonal allergic rhinitis.
D000293:Adolescent; D000328:Adult; D002648:Child; D002744:Chlorpheniramine / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004205:Cromolyn Sodium / Q000009:adverse effects / Q000627:therapeutic use*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007073:Immunoglobulin E / Q000032:analysis; D008297:Male; D008875:Middle Aged; D009666:Nose / Q000187:drug effects; D011058:Pollen; D011852:Radioallergosorbent Test; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy* / Q000276:immunology
D007073:Immunoglobulin E; D002744:Chlorpheniramine; D004205:Cromolyn Sodium